Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10929539 | 1.00 | CA2 (0.34) | CA2PIK3CDALDH1A1EPHX2 | |
| SCHEMBL20175910 | 1.00 | CA2 (0.34) | CA2PIK3CDALDH1A1EPHX2 | |
| SCHEMBL811322 | 1.00 | CA2 (0.34) | CA2PIK3CDALDH1A1EPHX2 | |
| SCHEMBL47033 | 0.91 | — | — | |
| SCHEMBL28164439 | 0.91 | PIK3CD (0.35) | PIK3CDALDH1A1 | |
| SCHEMBL5024988 | 0.89 | MEN1 (0.48) | ALDH1A1EPHX2 | |
| SCHEMBL987686 | 0.88 | EPHX2 (0.33) | ALDH1A1EPHX2 | |
| SCHEMBL863208 | 0.88 | EPHX2 (0.33) | ALDH1A1EPHX2 | |
| SCHEMBL863289 | 0.88 | EPHX2 (0.33) | ALDH1A1EPHX2 | |
| SCHEMBL987158 | 0.88 | EPHX2 (0.33) | ALDH1A1EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3672601-B1 | PROCESSES FOR PREPARING PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS VIA FAST-FLOW SYNTHESIS | SAREPTA THERAPEUTICS INC (US) | 2023-09-13 | — | — | EP | disclosed |
| US-11732008-B2 | Preparation of functional homocysteine residues in polypeptides and peptides | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-08-22 | — | — | US | disclosed |
| US-20230193067-A1 | METAL OXIDE COMPOSITION, LIGHT-EMITTING DEVICE USING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-06-22 | — | — | US | disclosed |
| US-11667652-B2 | MCL1 inhibitors | GILEAD SCIENCES, INC. (US) | 2023-06-06 | — | — | US | disclosed |
| CN-108690045-B | Diarylethene compounds and uses thereof | 首诺加拿大公司 | 2022-08-30 | — | — | CN | disclosed |
| CN-113304729-B | Mixture containing polyethylene glycol derivatives and application thereof | 苏州工业园区森耀环保科技有限公司 | 2021-10-19 | — | — | CN | disclosed |
| WO-2021195599-A1 | MTORC1 MODULATORS AND USES THEREOF | AEOVIAN PHARMACEUTICALS, INC. (US) | 2021-09-30 | — | — | WO | disclosed |
| CN-113304729-A | Mixture containing polyethylene glycol derivatives and application thereof | 苏州工业园区森耀环保科技有限公司 | 2021-08-27 | — | — | CN | disclosed |
| WO-2019060862-A1 | PROCESSES FOR PREPARING PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS VIA FAST-FLOW SYNTHESIS | SAREPTA THERAPEUTICS, INC. (US) | 2019-03-28 | — | — | WO | disclosed |
| US-20180210240-A1 | OPTICAL FILTER WITH LIGHT SOURCE | SWITCH MATERIALS, INC. (CA) | 2018-07-26 | — | — | US | disclosed |
| US-20130011751-A1 | METAL OXYGEN BATTERY | HONDA MOTOR CO., LTD. (JP) | 2013-01-10 | — | — | US | disclosed |
| US-20120270934-A1 | PROSTACYCLIN DERIVATIVES | CONCERT PHARMACEUTICALS, INC. | 2012-10-25 | — | — | US | disclosed |
| US-8093349-B2 | Terminally modified polybranched polyimide, metal-plated terminally modified polybranched polyimide, and method for producing the same | UBE INDUSTRIES, LTD. (JP) | 2012-01-10 | — | — | US | disclosed |
| US-20100009206-A1 | TERMINALLY MODIFIED POLYBRANCHED POLYIMIDE, METAL-PLATED TERMINALLY MODIFIED POLYBRANCHED POLYIMIDE, AND METHOD FOR PRODUCING THE SAME | UBE INDUSTRIES, LTD. (JP) | 2010-01-14 | — | — | US | disclosed |
| US-6929856-B2 | Dicing tape | UBE INDUSTRIES, LTD. (JP) | 2005-08-16 | — | — | US | disclosed |
| US-6872457-B2 | Atomic oxygen-resistant film | UBE INDUSTRIES, LTD. (JP) | 2005-03-29 | — | — | US | disclosed |
| US-20040023043-A1 | Dicing tape | UBE INDUSTRIES, LTD., A JAPANESE CORPORATION (JP) | 2004-02-05 | — | — | US | disclosed |
| US-6686106-B2 | POLYIMIDESILOXANE COPOLYMERS | UBE INDUSTRIES, LTD. (JP) | 2004-02-03 | — | — | US | disclosed |
| US-20030026998-A1 | Atomic oxygen-resistant film | UBE INDUSTRIES, LTD. (JP) | 2003-02-06 | — | — | US | disclosed |
| US-20020001763-A1 | Photosensitive resin compositions, insulating films, and processes for formation of the films | UBE INDUSTRIES, LTD. | 2002-01-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11732008-B2 | Preparation of functional homocysteine residues in polypeptides and peptides | BHMT2, BHMT, PTMS | CA2 3667/4885PIK3CD 3984/4885ALDH1A1 4389/4885 |
| US-20120270934-A1 | PROSTACYCLIN DERIVATIVES | PTGIS, PTGIR, PTGER1 | CA2 526/4885PIK3CD 1110/4885ALDH1A1 1386/4885 |
| US-11667652-B2 | MCL1 inhibitors | MCL1, BCL2L1, BCLAF1 | CA2 4494/4885PIK3CD 864/4885ALDH1A1 946/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.